Literature DB >> 28508315

TRPC Channels and Parkinson's Disease.

Pramod Sukumaran1, Yuyang Sun1, Anne Schaar1, Senthil Selvaraj1, Brij B Singh2.   

Abstract

Parkinson's disease (PD) is a common neurodegenerative disorder, which involves degeneration of dopaminergic neurons that are present in the substantia nigra pars compacta (SNpc) region. Many factors have been identified that could lead to Parkinson's disease; however, almost all of them are directly or indirectly dependent on Ca2+ signaling. Importantly, though disturbances in Ca2+ homeostasis have been implicated in Parkinson's disease and other neuronal diseases, the identity of the calcium channel remains elusive. Members of the transient receptor potential canonical (TRPC) channel family have been identified as a new class of Ca2+ channels, and it could be anticipated that these channels could play important roles in neurodegenerative diseases, especially in PD. Thus, in this chapter we have entirely focused on TRPC channels and elucidated its role in PD.

Entities:  

Keywords:  Calcium signaling; Dopaminergic neurons; ER stress; Oxidative stress; Parkinson’s disease

Mesh:

Substances:

Year:  2017        PMID: 28508315      PMCID: PMC5937936          DOI: 10.1007/978-94-024-1088-4_8

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  98 in total

1.  The Na+/K+-ATPase and the amyloid-beta peptide aβ1-40 control the cellular distribution, abundance and activity of TRPC6 channels.

Authors:  Sylvain Chauvet; Marielle Boonen; Mireille Chevallet; Louis Jarvis; Addis Abebe; Mohamed Benharouga; Peter Faller; Michel Jadot; Alexandre Bouron
Journal:  Biochim Biophys Acta       Date:  2015-09-05

2.  Activation of the unfolded protein response in Parkinson's disease.

Authors:  J J M Hoozemans; E S van Haastert; P Eikelenboom; R A I de Vos; J M Rozemuller; W Scheper
Journal:  Biochem Biophys Res Commun       Date:  2007-01-17       Impact factor: 3.575

3.  Constitutively active TRPC3 channels regulate basal ganglia output neurons.

Authors:  Fu-Wen Zhou; Shannon G Matta; Fu-Ming Zhou
Journal:  J Neurosci       Date:  2008-01-09       Impact factor: 6.167

Review 4.  TRP channels entering the structural era.

Authors:  Rachelle Gaudet
Journal:  J Physiol       Date:  2008-06-05       Impact factor: 5.182

Review 5.  TRP channels: new potential therapeutic approaches in CNS neuropathies.

Authors:  Maria Beatrice Morelli; Consuelo Amantini; Sonia Liberati; Matteo Santoni; Massimo Nabissi
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-03       Impact factor: 4.388

6.  Calpain cleaves and activates the TRPC5 channel to participate in semaphorin 3A-induced neuronal growth cone collapse.

Authors:  J Stefan Kaczmarek; Antonio Riccio; David E Clapham
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-30       Impact factor: 11.205

7.  TRPC1 inhibits apoptotic cell degeneration induced by dopaminergic neurotoxin MPTP/MPP(+).

Authors:  Senthil Selvaraj; John A Watt; Brij B Singh
Journal:  Cell Calcium       Date:  2009-08-19       Impact factor: 6.817

8.  Mobilization of calcium from intracellular stores facilitates somatodendritic dopamine release.

Authors:  Jyoti C Patel; Paul Witkovsky; Marat V Avshalumov; Margaret E Rice
Journal:  J Neurosci       Date:  2009-05-20       Impact factor: 6.167

9.  Brain-derived neurotrophic factor levels in Alzheimer's disease.

Authors:  Sid E O'Bryant; Valerie Hobson; James R Hall; Stephen C Waring; Wenyan Chan; Paul Massman; Laura Lacritz; C Munro Cullum; Ramon Diaz-Arrastia
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

10.  Knockout of the trcp3 gene causes a recessive neuromotor disease in mice.

Authors:  Magdalena Rodríguez-Santiago; Merit Mendoza-Torres; Juan Francisco Jiménez-Bremont; Rubén López-Revilla
Journal:  Biochem Biophys Res Commun       Date:  2007-07-06       Impact factor: 3.575

View more
  5 in total

Review 1.  TRPC channels: Structure, function, regulation and recent advances in small molecular probes.

Authors:  Hongbo Wang; Xiaoding Cheng; Jinbin Tian; Yuling Xiao; Tian Tian; Fuchun Xu; Xuechuan Hong; Michael X Zhu
Journal:  Pharmacol Ther       Date:  2020-01-28       Impact factor: 12.310

Review 2.  Canonical transient receptor potential channels and their modulators: biology, pharmacology and therapeutic potentials.

Authors:  Yuan-Yuan Gao; Wen Tian; Hui-Nan Zhang; Yang Sun; Jing-Ru Meng; Wei Cao; Xiao-Qiang Li
Journal:  Arch Pharm Res       Date:  2021-03-24       Impact factor: 4.946

Review 3.  Transient Receptor Potential Channels as an Emerging Target for the Treatment of Parkinson's Disease: An Insight Into Role of Pharmacological Interventions.

Authors:  Bhupesh Vaidya; Shyam Sunder Sharma
Journal:  Front Cell Dev Biol       Date:  2020-11-20

4.  Increase in membrane surface expression and phosphorylation of TRPC3 related to olfactory dysfunction in α-synuclein transgenic mice.

Authors:  Min Chen; Jia Liu; Hanjiang Luo; Chunli Duan; Ge Gao; Hui Yang
Journal:  J Cell Mol Med       Date:  2022-08-27       Impact factor: 5.295

Review 5.  Calmodulin and Its Binding Proteins in Parkinson's Disease.

Authors:  Anastasiia Bohush; Wiesława Leśniak; Serge Weis; Anna Filipek
Journal:  Int J Mol Sci       Date:  2021-03-16       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.